Association Between Growth Differentiation Factor-15 and Coagulation Parameters in Male Chinese Patients With

Huan Liu1, Yongnan Lyu2, Wen Dai1

  • 1Department of Clinical Laboratory, Renmin Hospital of Wuhan University, 430060 Wuhan, Hubei, China.

PubMed

Insights

Growth Differentiation Factor-15 (GDF-15) levels in male coronary artery disease (CAD) patients correlate with coagulation markers. GDF-15 may indicate coagulation instability in CAD, particularly acute coronary syndrome (ACS).

Area of Science:

  • Cardiovascular Medicine
  • Biomarkers
  • Hematology

Background:

  • Growth Differentiation Factor-15 (GDF-15) is a novel biomarker for coronary artery disease (CAD).
  • The role of GDF-15 in the hypercoagulable state of CAD is not well understood.
  • This study investigated the relationship between GDF-15 and coagulation parameters in male Chinese CAD patients.

Purpose of the Study:

  • To explore the association between serum GDF-15 levels and various coagulation parameters in male patients with CAD.
  • To determine if GDF-15 can serve as a biomarker for coagulation status in CAD.
  • To investigate GDF-15's role in different CAD subgroups, including acute myocardial infarction (AMI) and stable angina (SA).

Main Methods:

  • A cohort of 892 subjects (592 with CAD, 300 controls) was analyzed.
  • Serum GDF-15, blood cell counts, lipids, glucose, and coagulation parameters were measured.
  • Statistical analyses included Kruskal-Wallis, ANOVA, and univariate/multivariate linear regression.

Main Results:

  • GDF-15 levels were significantly higher in CAD patients (AMI and SA) compared to controls.
  • GDF-15 positively correlated with activated partial thromboplastin time (APTT) and inversely with antithrombin III (AT3) in CAD patients.
  • In AMI patients, GDF-15 was associated with APTT and monocyte count; in SA patients, it was inversely associated with AT3.

Conclusions:

  • Elevated GDF-15 in male CAD patients is linked to altered coagulation parameters.
  • GDF-15 may act as a compensatory marker for coagulation instability in CAD.
  • GDF-15 shows potential as a biomarker for assessing coagulation status in CAD, especially in ACS.
Abstract

Related Concept Videos

Coronary Artery Disease I: Introduction01:30

Coronary Artery Disease I: Introduction

Coronary Artery Disease (CAD): An Overview with Scientific InsightsCoronary Artery Disease (CAD), often referred to as C-A-D, is a prevalent blood vessel disorder classified under the broader category of atherosclerosis. Atherosclerosis is a pathological process characterized by the hardening and narrowing of arteries due to the accumulation of atherosclerotic plaques. These plaques are composed of cholesterol, fatty substances, inflammatory cells, calcium, and fibrin, reducing blood flow to...
1.2K
Coronary Artery Disease II: Pathophysiology01:26

Coronary Artery Disease II: Pathophysiology

Coronary Artery Disease (CAD) originates from a series of events that impair the function of coronary arteries, the blood vessels responsible for delivering oxygen-rich blood to the heart muscle. The pathophysiology of CAD is closely linked to atherosclerosis, a chronic inflammatory and lipid-driven condition affecting the vascular endothelium.1. Endothelial DamageThe process begins with damage to the vascular endothelium, which serves as a protective barrier between the blood and the vessel...
510
Coronary Artery Disease V: Interprofessional Care01:27

Coronary Artery Disease V: Interprofessional Care

Interprofessional care for coronary artery disease includes pharmacological therapy and revascularization procedures.Pharmacological therapy for Coronary Artery Disease (CAD) aims to manage symptoms, prevent complications, and improve patient outcomes through various classes of medications:Antiplatelet Agents:Aspirin and Clopidogrel: These medications inhibit platelet aggregation, preventing blood clots, which is crucial for avoiding heart attacks and strokes. Doctors often prescribe these...
298
Coronary Artery Disease III: Clinical Manifestations01:30

Coronary Artery Disease III: Clinical Manifestations

Coronary Artery Disease (CAD) is a primary health risk worldwide, leading to significant morbidity and mortality. The condition arises from the buildup of atherosclerotic plaques within the coronary arteries, resulting in diminished blood supply to the heart muscle.The clinical manifestations of CAD vary widely, from asymptomatic stages to severe, life-threatening conditions. Understanding these manifestations is crucial for early diagnosis and effective management.Angina Pectoris: The Warning...
411
Coronary Artery Disease IV: Preventive Measures01:26

Coronary Artery Disease IV: Preventive Measures

Effective preventive measures for coronary artery disease (CAD) focus on controlling modifiable risk factors, including cholesterol abnormalities and lifestyle changes.Cholesterol ManagementFirst, the Mediterranean diet and the American Heart Association advocate for maintaining low-density lipoprotein (LDL) cholesterol levels below 100 mg/dL, with a more stringent recommendation of below 70 mg/dL for individuals at high risk. LDL cholesterol, often termed "bad cholesterol," can lead to the...
728
Coagulation01:06

Coagulation

Colloidal solids are solid particles suspended in solution. They are usually negatively charged, attracting a compact primary layer of positively charged ions, which attract more counterions to form an electrical double layer. Electrostatic repulsion between the charged double layers prevents the particles from colliding, stabilizing the colloids. These solids are often undesirable because they can contain toxins that are difficult to remove. Coagulation is a technique that helps aggregate and...
1.5K